US Stock MarketDetailed Quotes

HSDTW HELIUS MEDICAL TECHNOLOGIES INC C/WTS 02/02/2026 (TO PUR COM)

Watchlist

0.000
0.0000.00%

15min DelayClose Jul 2 09:30 ET

0Market Cap0.00P/E (TTM)

HELIUS MEDICAL TECHNOLOGIES INC C/WTS 02/02/2026 (TO PUR COM) Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Total revenue

21.62%135K

-18.17%644K

-52.48%134K

-27.04%143K

115.13%256K

-41.58%111K

50.77%787K

9.30%282K

79.82%196K

67.61%119K

Operating revenue

16.98%124K

-22.24%605K

-56.23%123K

-32.31%132K

105.04%244K

-42.08%106K

57.81%778K

11.95%281K

91.18%195K

88.89%119K

Cost of revenue

0.82%123K

25.92%583K

-40.00%90K

85.15%187K

109.09%184K

-1.61%122K

55.37%463K

16.28%150K

17.44%101K

31.34%88K

Gross profit

209.09%12K

-81.17%61K

-66.67%44K

-146.32%-44K

132.26%72K

-116.67%-11K

44.64%324K

2.33%132K

313.04%95K

675.00%31K

Operating expense

-9.77%3.43M

-18.25%12.33M

-18.24%2.29M

-29.61%2.95M

-4.91%3.29M

-17.95%3.8M

-17.88%15.08M

-33.80%2.8M

-4.66%4.19M

-43.91%3.46M

Selling and administrative expenses

-8.39%2.63M

-12.87%9.27M

-17.03%1.63M

-35.28%2.2M

4.39%2.57M

1.95%2.87M

-12.61%10.64M

-17.21%1.97M

18.68%3.39M

-48.12%2.46M

Research and development costs

-11.06%788K

-30.97%2.94M

-18.14%650K

-3.86%722K

-28.23%684K

-49.77%886K

-28.85%4.26M

-56.08%794K

-49.56%751K

-30.79%953K

Depreciation amortization depletion

-82.05%7K

-35.36%117K

-80.00%8K

-31.91%32K

-19.15%38K

-17.02%39K

-9.50%181K

-14.89%40K

-2.08%47K

-4.08%47K

-Depreciation and amortization

-82.05%7K

-35.36%117K

-80.00%8K

-31.91%32K

-19.15%38K

-17.02%39K

-9.50%181K

-14.89%40K

-2.08%47K

-4.08%47K

Operating profit

10.34%-3.42M

16.87%-12.27M

15.85%-2.25M

26.90%-2.99M

6.15%-3.22M

16.52%-3.81M

18.65%-14.76M

34.93%-2.67M

6.33%-4.1M

44.37%-3.43M

Net non-operating interest income expense

-108.00%-8K

130.82%257K

107.40%68K

89K

100K

-834K

85K

-919K

Total other finance cost

108.00%8K

-130.82%-257K

--0

-107.40%-68K

---89K

---100K

--834K

---85K

--919K

----

Other net income (expense)

-25.33%908K

107.89%3.16M

152.17%1.2M

-118.49%-737K

490.00%1.48M

457.80%1.22M

15,110.00%1.52M

-2.3M

1,369.11%3.99M

-305.41%-380K

Gain on sale of security

-29.77%854K

42.71%3.24M

148.87%1.13M

-112.34%-585K

490.00%1.48M

460.37%1.22M

22,610.00%2.27M

---2.31M

1,610.19%4.74M

-305.41%-380K

Special income (charges)

----

79.00%-159K

--0

79.00%-159K

----

---757K

--0

---757K

----

-Less:Impairment of capital assets

----

-79.00%159K

--0

-79.00%159K

----

--757K

--0

--757K

----

Other non- operating income (expenses)

--54K

1,042.86%80K

1,116.67%73K

--7K

----

--7K

--6K

----

Income before tax

-0.88%-2.52M

37.11%-8.85M

78.61%-1.05M

-255.63%-3.66M

56.75%-1.65M

42.61%-2.49M

22.39%-14.07M

-19.11%-4.89M

78.02%-1.03M

36.30%-3.81M

Income tax

Net income

-0.88%-2.52M

37.11%-8.85M

78.61%-1.05M

-255.63%-3.66M

56.75%-1.65M

42.61%-2.49M

22.39%-14.07M

-19.11%-4.89M

78.02%-1.03M

36.30%-3.81M

Net income continuous Operations

-0.88%-2.52M

37.11%-8.85M

78.61%-1.05M

-255.63%-3.66M

56.75%-1.65M

42.61%-2.49M

22.39%-14.07M

-19.11%-4.89M

78.02%-1.03M

36.30%-3.81M

Minority interest income

Net income attributable to the parent company

-0.88%-2.52M

37.11%-8.85M

78.61%-1.05M

-255.63%-3.66M

56.75%-1.65M

42.61%-2.49M

22.39%-14.07M

-19.11%-4.89M

78.02%-1.03M

36.30%-3.81M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

-0.88%-2.52M

37.11%-8.85M

78.61%-1.05M

-255.63%-3.66M

56.75%-1.65M

42.61%-2.49M

22.39%-14.07M

-19.11%-4.89M

78.02%-1.03M

36.30%-3.81M

Basic earnings per share

Diluted earnings per share

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Total revenue	21.62%135K	-18.17%644K	-52.48%134K	-27.04%143K	115.13%256K	-41.58%111K	50.77%787K	9.30%282K	79.82%196K	67.61%119K
Operating revenue	16.98%124K	-22.24%605K	-56.23%123K	-32.31%132K	105.04%244K	-42.08%106K	57.81%778K	11.95%281K	91.18%195K	88.89%119K
Cost of revenue	0.82%123K	25.92%583K	-40.00%90K	85.15%187K	109.09%184K	-1.61%122K	55.37%463K	16.28%150K	17.44%101K	31.34%88K
Gross profit	209.09%12K	-81.17%61K	-66.67%44K	-146.32%-44K	132.26%72K	-116.67%-11K	44.64%324K	2.33%132K	313.04%95K	675.00%31K
Operating expense	-9.77%3.43M	-18.25%12.33M	-18.24%2.29M	-29.61%2.95M	-4.91%3.29M	-17.95%3.8M	-17.88%15.08M	-33.80%2.8M	-4.66%4.19M	-43.91%3.46M
Selling and administrative expenses	-8.39%2.63M	-12.87%9.27M	-17.03%1.63M	-35.28%2.2M	4.39%2.57M	1.95%2.87M	-12.61%10.64M	-17.21%1.97M	18.68%3.39M	-48.12%2.46M
Research and development costs	-11.06%788K	-30.97%2.94M	-18.14%650K	-3.86%722K	-28.23%684K	-49.77%886K	-28.85%4.26M	-56.08%794K	-49.56%751K	-30.79%953K
Depreciation amortization depletion	-82.05%7K	-35.36%117K	-80.00%8K	-31.91%32K	-19.15%38K	-17.02%39K	-9.50%181K	-14.89%40K	-2.08%47K	-4.08%47K
-Depreciation and amortization	-82.05%7K	-35.36%117K	-80.00%8K	-31.91%32K	-19.15%38K	-17.02%39K	-9.50%181K	-14.89%40K	-2.08%47K	-4.08%47K
Operating profit	10.34%-3.42M	16.87%-12.27M	15.85%-2.25M	26.90%-2.99M	6.15%-3.22M	16.52%-3.81M	18.65%-14.76M	34.93%-2.67M	6.33%-4.1M	44.37%-3.43M
Net non-operating interest income expense	-108.00%-8K	130.82%257K	0	107.40%68K	89K	100K	-834K	85K	-919K	0
Total other finance cost	108.00%8K	-130.82%-257K	--0	-107.40%-68K	---89K	---100K	--834K	---85K	--919K	----
Other net income (expense)	-25.33%908K	107.89%3.16M	152.17%1.2M	-118.49%-737K	490.00%1.48M	457.80%1.22M	15,110.00%1.52M	-2.3M	1,369.11%3.99M	-305.41%-380K
Gain on sale of security	-29.77%854K	42.71%3.24M	148.87%1.13M	-112.34%-585K	490.00%1.48M	460.37%1.22M	22,610.00%2.27M	---2.31M	1,610.19%4.74M	-305.41%-380K
Special income (charges)	----	79.00%-159K	--0	79.00%-159K	----	----	---757K	--0	---757K	----
-Less:Impairment of capital assets	----	-79.00%159K	--0	-79.00%159K	----	----	--757K	--0	--757K	----
Other non- operating income (expenses)	--54K	1,042.86%80K	1,116.67%73K	--7K	----	----	--7K	--6K	----	----
Income before tax	-0.88%-2.52M	37.11%-8.85M	78.61%-1.05M	-255.63%-3.66M	56.75%-1.65M	42.61%-2.49M	22.39%-14.07M	-19.11%-4.89M	78.02%-1.03M	36.30%-3.81M
Income tax	0	0	0	0	0	0	0	0	0	0
Net income	-0.88%-2.52M	37.11%-8.85M	78.61%-1.05M	-255.63%-3.66M	56.75%-1.65M	42.61%-2.49M	22.39%-14.07M	-19.11%-4.89M	78.02%-1.03M	36.30%-3.81M
Net income continuous Operations	-0.88%-2.52M	37.11%-8.85M	78.61%-1.05M	-255.63%-3.66M	56.75%-1.65M	42.61%-2.49M	22.39%-14.07M	-19.11%-4.89M	78.02%-1.03M	36.30%-3.81M
Minority interest income
Net income attributable to the parent company	-0.88%-2.52M	37.11%-8.85M	78.61%-1.05M	-255.63%-3.66M	56.75%-1.65M	42.61%-2.49M	22.39%-14.07M	-19.11%-4.89M	78.02%-1.03M	36.30%-3.81M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	-0.88%-2.52M	37.11%-8.85M	78.61%-1.05M	-255.63%-3.66M	56.75%-1.65M	42.61%-2.49M	22.39%-14.07M	-19.11%-4.89M	78.02%-1.03M	36.30%-3.81M
Basic earnings per share
Diluted earnings per share
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall